Alan Mark Nieder

Alan Nieder practices at Mount Sinai Medical Center in Miami Beach, Florida, part of Mount Sinai Medical Center of Florida.

Alan Nieder's NPI, 1578503538, was assigned on June 7, 2006. Alan Nieder graduated from New York University School of Medicine in 1997. Alan Nieder holds Florida license ME87075.

Alan Nieder's primary practice is Mount Sinai Medical Center, at 4300 Alton Rd, Miami Beach, FL 33140 in Miami-Dade County. The practice phone is (305) 674-2121.

Alan Nieder's primary practice is Mount Sinai Medical Center in Miami Beach, Florida, part of Mount Sinai Medical Center of Florida. Alan Nieder is also affiliated with Lower Keys Medical Center. The medical group on file is Mount Sinai Medical Center. Dmand AI also links Alan Nieder to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Alan Nieder practices, 4 sites in all. Vendor and product names are available with a free account.

Urology is Alan Nieder's primary specialty in the NPI Registry, under taxonomy code 208800000X. Alan Nieder is board certified in urology by the American Board of Urology. Dmand AI has Alan Nieder's licenses on file in 2 states: Florida and New York.

Dmand AI lists bladder disease, bladder removal, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney disease and kidney removal surgery among the conditions Alan Nieder treats.

CMS data shows 1,639 Medicare services from Alan Nieder across 15 procedure codes in 2024, for 607 Medicare patients. Medicare paid $177,948 for them.

CMS counts 607 Medicare patients who saw Alan Nieder in 2024. The largest group is 75 to 84, with 275 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.38, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Alan Nieder's median patient age at 73, with 16% women.

In 2024, Alan Nieder wrote 1,002 Medicare Part D claims for 330 patients. 92% of them were for generic drugs. CMS names the drug for 859 of them, across 16 drugs with 11 or more claims each, at $79,919 in total drug cost. In 2023, CMS named 827 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Alan Nieder for performance year 2024, reported as part of a group. Alan Nieder accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Alan Nieder as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 72 papers to Alan Nieder, published from 2004 to 2025. 2022 was the busiest year, with 5. The most frequent topics are Urinary Bladder Neoplasms, Prostatic Neoplasms and Carcinoma, Transitional Cell. Alan Nieder has published most often in Urology. Alan Nieder's most frequent co-authors are Mark S. Soloway, MD, Murugesan Manoharan, MD and Akshay Bhandari, MD.

CMS Open Payments shows 571 general payments to Alan Nieder from 67 drug and device companies from 2016 to 2025. Honoraria make up the largest share, 33% of the total. Urogen Pharma, Inc. paid the most, $35,122. It also lists 1 research payment totaling $510 in 2016.

Dmand AI lists 3 awards for Alan Nieder, most recently America's Top Doctors in 2014.

Alan Nieder graduated from New York University School of Medicine in 1997.

Alan Nieder is in network with 18 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.